Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neurocrine Biosciences (NBIX) Tax Rate (2019 - 2025)

Neurocrine Biosciences' Tax Rate history spans 7 years, with the latest figure at 35.8% for Q4 2025.

  • For Q4 2025, Tax Rate fell 80.0% year-over-year to 35.8%; the TTM value through Dec 2025 reached 32.15%, up 238.0%, while the annual FY2025 figure was 32.15%, 238.0% up from the prior year.
  • Tax Rate reached 35.8% in Q4 2025 per NBIX's latest filing, up from 28.2% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 47.1% in Q4 2021 to a low of 25.8% in Q1 2024.
  • Average Tax Rate over 5 years is 25.96%, with a median of 28.16% recorded in 2023.
  • Peak YoY movement for Tax Rate: surged 78139bps in 2021, then tumbled -5164bps in 2024.
  • A 5-year view of Tax Rate shows it stood at 47.1% in 2021, then tumbled by -48bps to 24.51% in 2022, then increased by 4bps to 25.48% in 2023, then skyrocketed by 44bps to 36.59% in 2024, then fell by -2bps to 35.8% in 2025.
  • Per Business Quant, the three most recent readings for NBIX's Tax Rate are 35.8% (Q4 2025), 28.2% (Q3 2025), and 32.6% (Q2 2025).